insulin receptor ir transmembrane receptor activated insulin igfi igfii belongs large class receptor tyrosine metabolically insulin receptor plays key role regulation glucose homeostasis functional process degenerate conditions may result range clinical manifestations including diabetes insulin signalling controls access blood glucose body cells insulin falls especially high insulin sensitivity body cells begin access lipids require transport across membrane way insulin key regulator fat metabolism well biochemically insulin receptor encoded single gene insr alternate splicing transcription results either ira irb downstream posttranslational events either isoform result formation proteolytically cleaved α β subunit upon combination ultimately capable homo heterodimerisation produce kda disulfidelinked transmembrane insulin initially transcription alternative splice variants derived insr gene translated form one two monomeric isomers ira exon excluded irb exon included inclusion exon results addition amino acids upstream intrinsic furin proteolytic cleavage site upon receptor dimerisation proteolytic cleavage α βchains additional amino acids remain present cterminus αchain designated αct predicted influence isometric monomer structurally organized distinct domains consists leucinerich repeat domain residues cysteinerich region cr residues additional leucine rich repeat domain residues three fibronectin type iii domains residues residues residues additionally insert domain id residues resides within containing αβ furin cleavage site proteolysis results idα idβ domains within βchain downstream domain lies transmembrane helix th intracellular juxtamembrane jm region upstream intracellular tyrosine kinase tk catalytic domain responsible subsequent intracellular signaling upon cleavage monomer respective α βchains receptor hetero homodimerisation maintained covalently chains single disulphide link monomers dimer two disulphide links extending αchain overall ectodomain structure possessing four ligand binding sites resembles inverted v monomer rotated approximately axis running parallel inverted v domains monomer forming inverted vs insulin receptors endogenous ligands include insulin igfi igfii using cryoem structural insight conformational changes upon insulin binding provided binding ligand αchains ir dimeric ectodomain shifts inverted vshape tshaped conformation change propagated structurally transmembrane domains get closer eventually leading autophosphorylation various tyrosine residues within intracellular tk domain changes facilitate recruitment specific adapter proteins insulin receptor substrate proteins irs addition src homology b aps protein phosphatases eventually promoting downstream processes involving blood glucose strictly speaking relationship ir ligand shows complex allosteric properties indicated use scatchard plots identified measurement ratio ir bound ligand unbound ligand follow linear relationship respect changes concentration ir bound ligand suggesting ir respective ligand share relationship cooperative furthermore observation rate irligand dissociation accelerated upon addition unbound ligand implies nature cooperation negative said differently initial binding ligand ir inhibits binding second active site exhibition allosteric models state ir monomer possesses insulin binding sites site binds classical binding surface insulin consisting plus αct domains site consisting loops junction predicted bind novel hexamer face binding site monomer contributing ir ectodomain exhibits mirrored complementarity nterminal site one monomer ultimately faces cterminal site second monomer also true monomers mirrored complement opposite side ectodomain structure current literature distinguishes complement binding sites designating second monomers site site nomenclature either site site site site models state ir may bind insulin molecule two binding surfaces via locations site site proximally faces site upon insulin binding specific site crosslinking via ligand monomers predicted occur ie monomer site insulin monomer site monomer site insulin monomer site accordance current mathematical modelling irinsulin kinetics two important consequences events insulin crosslinking aforementioned observation negative cooperation ir ligand subsequent binding ligand ir reduced physical action crosslinking brings ectodomain conformation required intracellular tyrosine phosphorylation events ensue ie events serve requirements receptor activation eventual maintenance blood glucose applying cryoem molecular dynamics simulations receptor reconstituted nanodiscs structure entire dimeric insulin receptor ectodomain four insulin molecules bound visualized therefore confirming directly showing biochemically predicted binding number smallmolecule insulin receptor agonists insulin receptor type tyrosine kinase receptor binding agonistic ligand triggers autophosphorylation tyrosine residues subunit phosphorylating partner addition phosphate groups generates binding site insulin receptor substrate subsequently activated via phosphorylation activated initiates signal transduction pathway binds phosphoinositide turn causing activation catalyses conversion phosphatidylinositol phosphatidylinositol acts secondary messenger induces activation phosphatidylinositol dependent protein kinase activates several kinases notably protein kinase b pkb also known akt pkb triggers translocation glucose transporter containing vesicles cell membrane via activation snare proteins facilitate diffusion glucose cell pkb also phosphorylates inhibits glycogen synthase kinase enzyme inhibits glycogen synthase therefore pkb acts start process glycogenesis ultimately reduces bloodglucose effect insulin glucose uptake metabolism insulin binds receptor turn starts many protein activation cascades include translocation transporter plasma membrane influx glucose glycogen synthesis glycolysis fatty acid synthesis signal transduction insulin end transduction process activated protein binds proteins embedded membrane activated acts secondary messenger within cell stimulate transcription insulinregulated genes first protein binds ptyr residue domain able bind sos turn catalyzes replacement bound gdp gtp ras g protein protein begins phosphorylation cascade culminating activation mitogenactivated protein kinase mapk enters nucleus phosphorylates various nuclear transcription factors glycogen synthesis also stimulated insulin receptor via case domain kinase binds ptyr activated convert membrane lipid phosphatidylinositol phosphatidylinositol indirectly activates protein kinase pkb akt via phosphorylation pkb phosphorylates several target proteins including glycogen synthase kinase responsible phosphorylating thus deactivating glycogen synthase phosphorylated deactivated prevented deactivating glycogen synthase roundabout manner insulin increases glycogen synthesis insulin molecule docked onto receptor effected action may released back extracellular environment may degraded cell degradation normally involves endocytosis insulinreceptor complex followed action insulin degrading enzyme insulin molecules degraded liver cells estimated typical insulin molecule finally degraded minutes initial release besides metabolic function insulin receptors also expressed immune cells macrophages b cells cells cells expression insulin receptors undetectable resting state upregulated upon tcell receptor tcr activation indeed insulin shown supplied exogenously promote vitro cell proliferation animal models insulin receptor signalling important maximizing potential effect cells acute infection main activity activation insulin receptor inducing glucose uptake reason insulin insensitivity decrease insulin receptor signaling leads diabetes mellitus type cells unable take glucose result hyperglycemia increase circulating glucose sequelae result diabetes patients insulin resistance may display acanthosis nigricans patients homozygous mutations insr gene described causes donohue syndrome leprechaunism autosomal recessive disorder results totally nonfunctional insulin receptor patients lowset often protuberant ears flared nostrils thickened lips severe growth retardation cases outlook patients extremely poor death occurring within first year life mutations gene cause less severe rabsonmendenhall syndrome patients characteristically abnormal teeth hypertrophic gingiva gums enlargement pineal gland diseases present fluctuations glucose level meal glucose initially high falls rapidly abnormally low genetic mutations insulin receptor gene cause severe insulin insulin receptor shown interact crystal structure insulin receptor kinase complex bisubstrate inhibitor crystallographic studies activation loop mutant insulin receptor tyrosine kinase phosphorylated insulin receptor tyrosine kinase complex peptide substrate atp analog crystal structure tyrosine kinase domain human insulin receptor crystal structure catalyticloop mutant insulin receptor tyrosine kinase crystal structure insulin receptor kinase complex domain aps crystal structure bps region complex insulin receptor tyrosine kinase crystal structure complex insulin receptor tyrosine kinase insulin receptor ir ectodomain complex fabs insulin receptor domains httpsenwikipediaorgwikiinsulinreceptor